Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Susceptibilities of oral bacteria and yeast to mammalian cathelicidins.

Guthmiller JM, Vargas KG, Srikantha R, Schomberg LL, Weistroffer PL, McCray PB Jr, Tack BF.

Antimicrob Agents Chemother. 2001 Nov;45(11):3216-9.

2.

SMAP29 congeners demonstrate activity against oral bacteria and reduced toxicity against oral keratinocytes.

Weistroffer PL, Joly S, Srikantha R, Tack BF, Brogden KA, Guthmiller JM.

Oral Microbiol Immunol. 2008 Apr;23(2):89-95. doi: 10.1111/j.1399-302X.2007.00389.x.

PMID:
18279175
3.

Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cells.

Ouhara K, Komatsuzawa H, Yamada S, Shiba H, Fujiwara T, Ohara M, Sayama K, Hashimoto K, Kurihara H, Sugai M.

J Antimicrob Chemother. 2005 Jun;55(6):888-96. Epub 2005 May 10.

PMID:
15886266
4.

The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection.

Brogden KA, Kalfa VC, Ackermann MR, Palmquist DE, McCray PB Jr, Tack BF.

Antimicrob Agents Chemother. 2001 Jan;45(1):331-4.

5.

Bactericidal activity of mammalian cathelicidin-derived peptides.

Travis SM, Anderson NN, Forsyth WR, Espiritu C, Conway BD, Greenberg EP, McCray PB Jr, Lehrer RI, Welsh MJ, Tack BF.

Infect Immun. 2000 May;68(5):2748-55.

6.

Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms.

Joly S, Maze C, McCray PB Jr, Guthmiller JM.

J Clin Microbiol. 2004 Mar;42(3):1024-9.

7.

Antimicrobial activity and bacterial-membrane interaction of ovine-derived cathelicidins.

Anderson RC, Hancock RE, Yu PL.

Antimicrob Agents Chemother. 2004 Feb;48(2):673-6.

8.

Efficacy of the de novo-derived antimicrobial peptide WLBU2 against oral bacteria.

Novak KF, Diamond WJ, Kirakodu S, Peyyala R, Anderson KW, Montelaro RC, Mietzner TA.

Antimicrob Agents Chemother. 2007 May;51(5):1837-9. Epub 2007 Feb 26.

9.

Antimicrobial and immunomodulatory properties of PGLa-AM1, CPF-AM1, and magainin-AM1: potent activity against oral pathogens.

McLean DT, McCrudden MT, Linden GJ, Irwin CR, Conlon JM, Lundy FT.

Regul Pept. 2014 Nov;194-195:63-8. doi: 10.1016/j.regpep.2014.11.002. Epub 2014 Nov 13.

PMID:
25447193
10.

Antimicrobial activity of synthetic human CAP18 peptides to Streptococcus sanguis isolated from patients with Beh├žet's disease.

Isogai E, Hirata M, Isogai H, Matuo K, Kimura K, Yokota K, Oguma K, Tojo M, Kaneko F, Kotake S, Ohno S.

Adv Exp Med Biol. 2003;528:195-200. No abstract available.

PMID:
12918689
11.

Antimicrobial activity of magainin analogues against anaerobic oral pathogens.

Genco CA, Maloy WL, Kari UP, Motley M.

Int J Antimicrob Agents. 2003 Jan;21(1):75-8.

PMID:
12507842
12.

Antimicrobial activity of rabbit CAP18-derived peptides.

Larrick JW, Hirata M, Shimomoura Y, Yoshida M, Zheng H, Zhong J, Wright SC.

Antimicrob Agents Chemother. 1993 Dec;37(12):2534-9.

13.

Short- and medium-chain fatty acids exhibit antimicrobial activity for oral microorganisms.

Huang CB, Alimova Y, Myers TM, Ebersole JL.

Arch Oral Biol. 2011 Jul;56(7):650-4. doi: 10.1016/j.archoralbio.2011.01.011. Epub 2011 Feb 17.

14.

Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients.

Laheij AM, de Soet JJ, von dem Borne PA, Kuijper EJ, Kraneveld EA, van Loveren C, Raber-Durlacher JE.

Support Care Cancer. 2012 Dec;20(12):3231-40. doi: 10.1007/s00520-012-1463-2. Epub 2012 Apr 26.

15.

Antimicrobial action of rabbit leukocyte CAP18(106-137).

Mason DJ, Dybowski R, Larrick JW, Gant VA.

Antimicrob Agents Chemother. 1997 Mar;41(3):624-9.

16.

[Antimicrobial effects of tea tree oil (Melaleuca alternifolia) on oral microorganisms].

Kulik E, Lenkeit K, Meyer J.

Schweiz Monatsschr Zahnmed. 2000;110(11):125-30. German.

PMID:
11374358
17.

In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria.

Altman H, Steinberg D, Porat Y, Mor A, Fridman D, Friedman M, Bachrach G.

J Antimicrob Chemother. 2006 Jul;58(1):198-201. Epub 2006 May 10.

PMID:
16687459
18.

Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.

Saiman L, Tabibi S, Starner TD, San Gabriel P, Winokur PL, Jia HP, McCray PB Jr, Tack BF.

Antimicrob Agents Chemother. 2001 Oct;45(10):2838-44.

19.

Antimicrobial activity of silver nitrate against periodontal pathogens.

Spacciapoli P, Buxton D, Rothstein D, Friden P.

J Periodontal Res. 2001 Apr;36(2):108-13.

PMID:
11327077
20.

Antimicrobial activity of Mahonia aquifolium and two of its alkaloids against oral bacteria.

Rohrer U, Kunz EM, Lenkeit K, Schaffner W, Meyer J.

Schweiz Monatsschr Zahnmed. 2007;117(11):1126-31.

PMID:
18072463

Supplemental Content

Support Center